Intravenous immunoglobulin in two children with Guillain-Barré syndrome

L. D. Notarangelo, M. Duse, S. Tiberti, B. Guarneri, A. Brunori, A. Negrini, A. G. Ugazio

Research output: Contribution to journalArticle


Two children with Guillain-Barrè syndrome were succesfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.

Original languageEnglish
Pages (from-to)372-374
Number of pages3
JournalEuropean Journal of Pediatrics
Issue number4
Publication statusPublished - Apr 1993



  • Guillain-Barrè syndrome
  • Intravenous immunoglobulin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Notarangelo, L. D., Duse, M., Tiberti, S., Guarneri, B., Brunori, A., Negrini, A., & Ugazio, A. G. (1993). Intravenous immunoglobulin in two children with Guillain-Barré syndrome. European Journal of Pediatrics, 152(4), 372-374.